Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 241 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Actual shortage | 2024-02-22 | 2024-05-30 | 220261 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Actual shortage | 2024-06-07 | 2024-06-07 | 229963 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2020-03-06 | 2020-04-02 | 107978 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139743 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-09-07 | 2022-12-22 | 168744 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2020-02-21 | 2020-05-01 | 106931 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141107 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
| TEVA-CARVEDILOL | 3.125MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-16 | 227471 |
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-01-30 | 2020-05-29 | 104930 |
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-09-25 | 2020-10-22 | 125031 |
| TEVA-AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60068 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-23 | 224895 |
| TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3118 |
| TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118951 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2020-05-14 | 2020-07-23 | 115199 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-01-22 | 2021-02-25 | 132254 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-03-04 | 2021-04-01 | 135111 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-03-11 | 2021-03-25 | 135549 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-04-08 | 2021-05-27 | 137206 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |